AU8282498A - A senescence gene and its use in the treatment of cancer and other diseases - Google Patents

A senescence gene and its use in the treatment of cancer and other diseases

Info

Publication number
AU8282498A
AU8282498A AU82824/98A AU8282498A AU8282498A AU 8282498 A AU8282498 A AU 8282498A AU 82824/98 A AU82824/98 A AU 82824/98A AU 8282498 A AU8282498 A AU 8282498A AU 8282498 A AU8282498 A AU 8282498A
Authority
AU
Australia
Prior art keywords
cancer
diseases
treatment
senescence gene
senescence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82824/98A
Other languages
English (en)
Inventor
Michael J Bertram
Nathalie Berube
James K. Leung
Yi Ning
Olivia M Pereira-Smith
Qitao Ran
Xin Swanson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU8282498A publication Critical patent/AU8282498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU82824/98A 1997-07-03 1998-07-02 A senescence gene and its use in the treatment of cancer and other diseases Abandoned AU8282498A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5162697P 1997-07-03 1997-07-03
US60051626 1997-07-03
US98584597A 1997-12-05 1997-12-05
US08985845 1997-12-05
PCT/US1998/013743 WO1999001465A1 (en) 1997-07-03 1998-07-02 A senescence gene and its use in the treatment of cancer and other diseases

Publications (1)

Publication Number Publication Date
AU8282498A true AU8282498A (en) 1999-01-25

Family

ID=26729652

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82824/98A Abandoned AU8282498A (en) 1997-07-03 1998-07-02 A senescence gene and its use in the treatment of cancer and other diseases

Country Status (3)

Country Link
EP (1) EP1001966A4 (de)
AU (1) AU8282498A (de)
WO (1) WO1999001465A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102225645B1 (ko) * 2018-12-21 2021-03-22 주식회사 마크로젠 노화 특이적 바이오마커
CN116157529A (zh) * 2020-12-22 2023-05-23 中国科学院动物研究所 鉴定和/或调节衰老的方法

Also Published As

Publication number Publication date
WO1999001465A1 (en) 1999-01-14
EP1001966A4 (de) 2002-09-18
EP1001966A1 (de) 2000-05-24

Similar Documents

Publication Publication Date Title
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU7718898A (en) Txu-7-pap immunotoxin and use thereof
IL129351A0 (en) Hiv and cancer treatment
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU6435398A (en) Prevention and treatment of hepatocellular cancer
AU1164601A (en) Therapeutic use and formulation
AU4803997A (en) Polymorphisms and new genes in the region of the human hemochromatosis gene
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU2418499A (en) Org-5222 in the treatment of depression
AU7058000A (en) 13 human colon and colon cancer associated proteins
PL347542A1 (en) Therapeutic product and its use
AU1520499A (en) Essential fungal genes and their use
AU1598599A (en) Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU3501700A (en) Human endokine alpha and methods of use
AU1678900A (en) A novel liposomal formulation useful in treatment of cancer and other proliferation diseases
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU6653698A (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU8282498A (en) A senescence gene and its use in the treatment of cancer and other diseases
AU5293198A (en) Promoter of the human endoglin gene and its use
AU4328399A (en) Nucleic acid-cobalamin complexes and their use in gene therapy
AU5871898A (en) Microparticles and their use in cancer treatment
AU3118395A (en) Oligonucleotides and their use
AU9358398A (en) Use of p-glycoprotein (pgp) inhibitors in the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase